Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel age-related gene expression signature associates with proliferation and disease progression in breast cancer. | Br J Cancer | 2022 | 35995935 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis identifies ENY2 as a predictor of recurrence and a regulator of telomere maintenance in hepatocellular carcinoma. | Front Oncol | 2022 | 35992857 | PubTator, text mining | PubMed |
| Non-muscle invasive bladder cancer biomarkers beyond morphology. | Front Oncol | 2022 | 35992775 | PubTator, text mining | PubMed |
| Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker. | Front Genet | 2022 | 35991576 | PubTator, text mining | PubMed |
| Comprehensive Analysis Identifies COL1A1, COL3A1, and POSTN as Key Genes Associated with Brain Metastasis in Patients with Breast Cancer. | Evid Based Complement Alternat Med | 2022 | 35990840 | PubTator, text mining | PubMed |
| Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma. | Comput Math Methods Med | 2022 | 35983531 | PubTator, text mining | PubMed |
| Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma. | Transl Cancer Res | 2022 | 35966326 | PubTator, text mining | PubMed |
| The synergistic effect of CDKN2B-AS1 and SPC25 on triple-negative breast cancer. | Ann Transl Med | 2022 | 35965791 | PubTator, text mining | PubMed |
| GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2022 | 35960100 | PubTator, text mining | PubMed |
| The Roles of Histone Post-Translational Modifications in the Formation and Function of a Mitotic Chromosome. | Int J Mol Sci | 2022 | 35955838 | PubTator, text mining | PubMed |
| Knockdown of CKAP2 Inhibits Proliferation, Migration, and Aggregate Formation in Aggressive Breast Cancer. | Cancers (Basel) | 2022 | 35954424 | PubTator, text mining | PubMed |
| KIF11: A potential prognostic biomarker for predicting bone metastasis-free survival of prostate cancer. | Oncol Lett | 2022 | 35949593 | PubTator, text mining | PubMed |
| PLK4 is a key molecule in the formation of PGCCs and promotes invasion and migration of progeny cells derived from PGCCs. | J Cancer | 2022 | 35912011 | PubTator, text mining | PubMed |
| Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence. | Stem Cells Int | 2022 | 35910534 | PubTator, text mining | PubMed |
| Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | Cancer Discov | 2022 | 35904492 | PubTator, text mining | PubMed |
| Human fibroblasts facilitate the generation of iPSCs-derived mammary-like organoids. | Stem Cell Res Ther | 2022 | 35902878 | PubTator, text mining | PubMed |
| PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. | Nat Immunol | 2022 | 35902637 | PubTator, text mining | PubMed |
| Identification of Novel Genes and Associated Drugs in Advanced Clear Cell Renal Cell Carcinoma by Bioinformatic Methods. | Tohoku J Exp Med | 2022 | 35896362 | PubTator, text mining | PubMed |
| Stemness Correlates Inversely with MHC Class I Expression in Pediatric Small Round Blue Cell Tumors. | Cancers (Basel) | 2022 | 35892842 | PubTator, text mining | PubMed |
| An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer. | Cancers (Basel) | 2022 | 35884419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=32